Data as of 12:08pm ET
| +0.01 / +0.25%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +11,900.00% increase from the last price of 4.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.